The fact that individuals with schizophrenia have high cardiovascular morbidity and mortality is well established. However, risk status and moderators or mediators in the earliest stages of illness are less clear.
The objective of the study is to assess cardiometabolic risk in first-episode schizophrenia (FES) spectrum disorders and its relationship to illness duration, antipsychotic treatment duration and type, sex, and race/ethnicity. Baseline results of the Recovery After an Initial Schizophrenia Episode (RAISE) study were collected between July 22, 2010, and July 5, 2012, from 34 community mental health facilities without major research, teaching, or clinical FES programs.
READ FULL ARTICLE From archpsyc.jamanetwork.com